SIERRA LEE: Open Payments
NPI 1700458437 · WOODSBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136 in 7 payments from 6 companies in 2025. Trend: 2023 $499 · 2024 $575 · 2025 $136
Food & beverage: $136
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $46 |
| Dexcom, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| TMS NeuroHealth Centers Inc. | 1 | $14 |
Products named: MOUNJARO, ZEPBOUND, Dexcom G6 Transmitter, VRAYLAR, Ozempic, JARDIANCE, TMS NeuroHealth Centers Inc..
Industry payments across MD — which companies pay providers there.
